New partnership with Regeneron yields promising results — Intellia Therapeutics (NASDAQ: NTLA) and its strategic partner Regeneron are on to something big in gene therapy and anticipation is building for future breakthroughs. Intellia is a biopharmaceutical research-driven innovator focused on the development of gene-editing therapies to help patients with autoimmune, genetic and oncology healthcare challenges.

Another global healthcare enterprise opts for the spinoff strategy to generate cash and streamline operations — John G. Baresky GlaxoSmithKline (GSK) is pulling the trigger on earlier considerations and spinning off its consumer products business unit as a separate company. It has been reported that GSK (NYSE: GSK) had a divestiture of its consumer products portfolio at least as far back as 2018. They are moving…

Merck spinoff builds up Women’s Healthcare assets — John G. Baresky Merck (NYSE: MRK) spinoff Organon (NYSE: OGN) has completed its acquisition of Alydia Health. …

A new treatment option for Alzheimer's is now available — John G. Baresky The FDA has approved Biogen’s (NASDAQ: BIIB) Aduhelm (aducanumab) for the treatment of Alzheimer’s disease, giving patients and medical professionals a desperately needed treatment option of which there are very few. Biogen developed the drug in collaboration with Tokyo, Japan-based Eisai, Co. (OTCMKTS: ESALY). It has been…

Data-driven patient care reflects healthcare industry trends — John G. Baresky HCA Healthcare (NYSE: HCA) and Google (Alphabet-Google NASDAQ: GOOGL) have entered into a deal involving advanced data analytics improving patient care and cost outcomes. Nashville-based HCA wants to learn more about its patient care performance and how to improve it based on analyzing data from patient records…

Walgreens continues successful COVID-19 vaccine campaign nationwide — John G. Baresky A recent survey of 1,500 patients receiving a COVID-19 vaccination reveals positive mental health benefits Walgreens (NASDAQ: WBA) has shared the encouraging results of an online survey they conducted designed to model the national outlook of those patients receiving a COVID-19 vaccination. The poll was conducted between April 19 to April 21, 2021, and based on data from:

Walmart fortifies its position as a growing healthcare provider organization and telehealth competitor — John G. Baresky Terms of the deal have not been revealed yet but Walmart (NYSE: WMT) has disclosed it is acquiring telehealth innovator MeMD. Founded in 2010, MeMD is a recognized leader in telehealth services nationwide.

Thermo Fisher Scientific’s transformation by acquisition continues — John G. Baresky Thermo Fisher Scientific (NYSE: TMO) has announced plans to acquire PPD (NASDAQ: PPD) for about $17.4 billion plus the assumption of PPD’s debt which stands around $3.5 billion. The combination of the two companies pairs two global giants in healthcare diagnostics, medical research and clinical services. Thermo…

Two global business leaders join forces to launch a large scale virtual health platform — John G. Baresky Paris-based financial services and insurance giant AXA (OTCMKTS: AXAHY) has selected enterprise technology leader Microsoft (NASDAQ: MSFT) as its partner to build a full-strength telehealth program for its clients and their members. AXA is one of the largest health insurers in the world. Its plans provide medical…